Interpace Biosciences Inc News

10-Q: Q2 2024 Earnings Report

Aug 9 04:20

8-K: Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results

Aug 3 04:36

8-K: Interpace Biosciences Announces First Quarter 2024 Financial and Business Results

May 10 04:35

10-Q: Q1 2024 Earnings Report

May 10 04:26

10-K/A: Annual report (Amendment)

Apr 27 04:45

Interpace Biosciences Inc | 10-K: FY2023 Annual Report

Apr 2 05:03

Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results

Mar 14 00:52

Interpace Biosciences Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Douglas M. Singer(5.78%)

Feb 13 06:06

Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Christopher

Feb 6 19:36

Interpace Biosciences Inc | 8-K: Current report

Dec 13, 2023 05:05

Interpace Biosciences Inc | 8-K: Current report

Nov 17, 2023 05:05

Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results

Nov 9, 2023 06:14

Interpace Biosciences Inc | 10-Q: Quarterly report

Nov 9, 2023 05:16

Interpace Biosciences Inc | 8-K: Current report

Oct 28, 2023 04:05

Interpace Biosciences Inc | DEFA14A: Others

Sep 23, 2023 04:53

Interpace Biosciences Inc | DEF 14A: Definitive information statements

Sep 23, 2023 04:20

Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results

Aug 10, 2023 03:47

Interpace Biosciences Inc | 10-Q: Q2 2023 Earnings Report

Aug 10, 2023 01:27

Interpace Biosciences Inc | 8-K: Current report

Aug 2, 2023 08:59

Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer McCarthy Christopher

Aug 2, 2023 05:24